© 2002 European Society of Cardiology
Hypoxia, angiotensin-II, and norepinephrine mediated apoptosis is stimulus specific in canine failed cardiomyocytes: a role for p38 MAPK, Fas-L and cyclin D1
Department of Medicine, Division of Cardiovascular Medicine, Henry Ford Heart and Vascular Institute Detroit, MI 48202, USA
* Corresponding author. Cardiovascular Research, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, USA. Tel.: +1-313-916-7360; fax: +1-313-916-3001 E-mail address: hsabbah1{at}hfhs.org
| Abstract |
|---|
Background: Apoptosis may contribute to the myocardial dysfunction associated with heart failure (HF). Activation of the p38 MAPK cascade can induce apoptosis in non-cardiac cells through increased expression of Fas-L, or through decreased expression of cyclin D1.
Aims: We tested the hypothesis that hypoxia (HX), angiotensin-II (A-II) and norepinephrine (NEPI) can mediate apoptosis by activating p38 MAPK, and thus initiating stimulus specific changes in Fas-L and cyclin D1 expression in failing cardiomyocytes.
Methods and results: Cardiomyocytes isolated from ten dogs with HF induced by coronary microembolizations were subjected to HX or A-II or NEPI with and without a p38 MAPK inhibitor (SB 203580). TUNEL staining for DNA fragmentation and Western blots for p38 MAPK, Fas-L and cyclin D1 detection were performed. HX-induced apoptosis was associated with increased Fas-L expression, A-II-induced apoptosis was associated with increased Fas-L and decreased cyclin D1 expression, and NEPI-induced apoptosis was associated with decreased cyclin D1 expression. Inhibition of p38 MAPK activity attenuated stress-induced apoptosis in all experiments and reversed changes in Fas-L and cyclin D1 expression.
Conclusions: HX, A-II and NEPI mediate apoptosis in failing cardiomyocytes via different effects on Fas-L and cyclin D1 expression. Inhibition of p38 MAPK reversed these effects, suggesting that apoptosis induced by HX, A-II and NEPI involves activation of p38 MAPK upstream from Fas-L and cyclin D1.
Key Words: Heart failure p38 MAPK Apoptosis Fas-L Cyclin D1
Received April 2, 2002; Revised July 9, 2002; Accepted September 17, 2002
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K.-i. Watanabe, M. Ma, K.-i. Hirabayashi, N. Gurusamy, P. T. Veeraveedu, P. Prakash, S. Zhang, A. J. Muslin, M. Kodama, and Y. Aizawa Swimming stress in DN 14-3-3 mice triggers maladaptive cardiac remodeling: role of p38 MAPK Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1269 - H1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. De Chiara, M. E. Marcocci, M. Torcia, M. Lucibello, P. Rosini, P. Bonini, Y. Higashimoto, G. Damonte, A. Armirotti, S. Amodei, et al. Bcl-2 Phosphorylation by p38 MAPK: IDENTIFICATION OF TARGET SITES AND BIOLOGIC CONSEQUENCES J. Biol. Chem., July 28, 2006; 281(30): 21353 - 21361. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Kim, A. Pedram, M. Razandi, and E. R. Levin Estrogen Prevents Cardiomyocyte Apoptosis through Inhibition of Reactive Oxygen Species and Differential Regulation of p38 Kinase Isoforms J. Biol. Chem., March 10, 2006; 281(10): 6760 - 6767. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Kaiser, O. F. Bueno, D. J. Lips, P. A. Doevendans, F. Jones, T. F. Kimball, and J. D. Molkentin Targeted Inhibition of p38 Mitogen-activated Protein Kinase Antagonizes Cardiac Injury and Cell Death Following Ischemia-Reperfusion in Vivo J. Biol. Chem., April 9, 2004; 279(15): 15524 - 15530. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhang, J. Ren, C. E. Zhang, I. Treskov, Y. Wang, and A. J. Muslin Role of 14-3-3-Mediated p38 Mitogen-Activated Protein Kinase Inhibition in Cardiac Myocyte Survival Circ. Res., November 28, 2003; 93(11): 1026 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gonzalez, M. A Fortuno, R. Querejeta, S. Ravassa, B. Lopez, N. Lopez, and J. Diez Cardiomyocyte apoptosis in hypertensive cardiomyopathy Cardiovasc Res, September 1, 2003; 59(3): 549 - 562. [Abstract] [Full Text] [PDF] |
||||



